Table 1. Clinical data of participating subjects.

Subjecta	Diagnosisb	Agec	Genderd	FEV1%e	IgE birchf
1	A	42	F	98	8
3	A	36	F	101	31
4	A	22	M	88	20
6	A	32	F	104	5
7	A	34	F	101	3
8	A	25	M	102	54
12	A	24	M	82	16
13	A	24	M	103	100
4	H	37	M	117	N/A
5	H	25	M	120	N/A
6	H	25	F	96	N/A
7g	H	26	F	97	N/A
8g	H	26	F	111	N/A
9h	H	22	M	99	N/A
10	H	25	M	99	N/A
11	H	23	F	99	N/A
12	H	24	F	99	N/A
13	H	26	M	105	N/A

^aSubject numbering is presented as originally published by Thunberg et al. [42].

^bAsthma (A), Healthy (H).

^cAge in years at time of study inclusion.

^dFemale (F), Male (M).

^eFEV₁% values at baseline. A Student's t-test of the groups indicated that there was no different between the two populations (p = 0.11).

^fkU/l required for 20% drop in FEV₁%, as reported by Thunberg et al. [42].

^gOxylipin profiling of subject 7 and 8 was performed in a pooled sample.

^hIndividual 9 was incorrectly reported by Thunberg et al. [42] and is a 22 year old male healthy individual.